Page 1 of Clinical Trials for Merck Frosst Canada Ltd. [SPONSOR-COLLABORATORS], 28 Total Matches
- 1CompletedLast Updated: November 5, 2008Condition(s): Type 1 Diabetes
- 2CompletedLast Updated: December 7, 2007Condition(s): Hypertension; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
- 3RecruitingLast Updated: October 6, 2005Condition(s): Chronic Kidney Disease
- 4RecruitingLast Updated: April 24, 2012Condition(s): Hematuria; Hematospermia
- 5Terminated
- 6CompletedLast Updated: September 22, 2011Condition(s): Heart Failure
- 7Enrolling by invitationLast Updated: July 19, 2011Condition(s): Human Papillomavirus Infection; Cervical Intraepithelial Neoplasia
- 8TerminatedLast Updated: August 11, 2009Condition(s): Osteoporosis
- 9CompletedLast Updated: March 4, 2011Condition(s): Microalbuminuria
- 10Not yet recruitingLast Updated: May 16, 2012Condition(s): Hyperlipidemia
- 11Recruiting
- 12TerminatedLast Updated: April 1, 2008Condition(s): Hypercholesterolemia; Atherosclerosis
- 13Active, not recruitingLast Updated: January 11, 2012Condition(s): Statin Therapy; Adherence
- 14CompletedLast Updated: July 19, 2011Condition(s): Hip Fracture
- 15RecruitingLast Updated: July 23, 2007Condition(s): Glaucoma
- 16RecruitingLast Updated: May 12, 2011Condition(s): Enlarged Prostate
- 17Active, not recruitingLast Updated: October 20, 2011Condition(s): Osteoporosis
- 18CompletedLast Updated: July 19, 2011Condition(s): Rhinosinusitis
- 19RecruitingLast Updated: March 11, 2010Condition(s): Asthma, Bronchial
- 20CompletedLast Updated: May 12, 2008Condition(s): Cardiovascular Diseases
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Merck+Frosst+Canada+Ltd.
